Open AccessAbstract 3193: Combination treatment with selinexor and bortezomib for management of highly aggressive neuroblastoma
Author(s) -
Basia Galinski,
Marcus Luxemburg,
Yosef Landesman,
Daniel A. Weiser
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3193
Subject(s) - bortezomib , neuroblastoma , proteasome inhibitor , cancer research , apoptosis , proteasome , pharmacology , cell growth , cell culture , biology , chemistry , immunology , multiple myeloma , microbiology and biotechnology , biochemistry , genetics